Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01967030 · ClinicalTrials.gov registry record
SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy
A clinical trial of Type 2 Diabetes, sponsored by Kaiser Permanente.
- Active
- Registry status
- 1,035
- Enrollment target
- 1
- Study location
NCT01967030 is a study of Type 2 Diabetes that is active but no longer recruiting, run by Kaiser Permanente. The registered enrollment target is 1,035 participants, roughly in line with the 1,099-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target. The trial reports 1 study location across 1 state.
The verdict
NCT01967030, a study of Type 2 Diabetes, is active but no longer recruiting, sponsored by Kaiser Permanente.
- ACTIVE NOT RECRUITING
- Registry status
- 1,035 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of the Study of Women, Infant Feeding and Type 2 Diabetes after GDM pregnancy (SWIFT) is to determine the relation of longer and more intensive lactation, as compared to formula feeding, on progression to incident type 2 diabetes mellitus among women within several years following delivery of a GDM pregnancy. The initial study enrolled women with recent GDM at 6 to 9 weeks post-delivery to reclassify oral glucose tolerance and conduct subsequent testing of glucose tolerance to ascertain progression to overt diabetes up to two years later. Research methods were utilized to assess lactation intensity and duration quantitatively and to evaluate incidence rates of diabetes, as well as changes in blood glucose levels, insulin resistance, body weight, waist circumference, and overall adiposity from baseline and up to several years later. SWIFT is a prospective, observational cohort study of 1,035 women recruited during pregnancy who were diagnosed with gestational diabetes mellitus (GDM) via Carpenter and Coustan criteria and enrolled into the research study. We assessed the natural history of progression to prediabetes and type 2 diabetes from early postpartum for a racially and ethnically diverse cohort of women with GDM (75% minority) at high-risk for developing overt diabetes within 5-10 years post-delivery.
Conditions Studied
Study Locations (1)
California
- Kaiser Permanente Northern California, Division of Research - Oakland
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,035 participants |
| Start Date | 2008-05 |
| Est. Completion | 2030-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01967030
The ClinicalTrials.gov registry entry for NCT01967030 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 1,035 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 1,099-participant average among 288 other Type 2 Diabetes trials with a reported enrollment target. The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Type 2 Diabetes appearing as the primary indexed condition, and to 0 interventions.
NCT01967030 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01967030 about?
NCT01967030 is a clinical study titled "SWIFT: Study of Women, Infant Feeding and Type 2 Diabetes After GDM Pregnancy". The overall goal of the Study of Women, Infant Feeding and Type 2 Diabetes after GDM pregnancy (SWIFT) is to determine the relation of longer and more intensive lactation, as compared to formula feeding, on progression to incident type 2 diabetes mellitus among women within several years following d...
What is the current status of trial NCT01967030?
This trial is currently active not recruiting. The enrollment target is 1,035 participants. The study started on 2008-05. Estimated completion is 2030-09.
What conditions does trial NCT01967030 study?
This clinical trial studies the following conditions: Type 2 Diabetes.
Who is sponsoring clinical trial NCT01967030?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01967030 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Type 2 Diabetes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Enhancing Telemedicine for T2D
RECRUITING · NA
-
Sleep and Glycemic Control in Type 2 Diabetes Adolescents
RECRUITING · NA
-
Enhancing Preventative Health Behaviors Among Emergency Department Hyperglycemic Patients
RECRUITING · NA
-
Ultrasound Effects on Glycemic Control in T2DM
RECRUITING · NA
-
Mechanism of SGLT2 Inhibition in the Kidney
RECRUITING · Phase 4
-
Acute and Chronic Effects of Oral Ketones in Subjects With HFrEF and Diabetes
RECRUITING · Early Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.